Fabry's disease medical therapy

Fabry's disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fabry's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fabry's disease medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fabry's disease medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fabry's disease medical therapy
CDC on Fabry's disease medical therapy
Fabry's disease medical therapy in the news
Blogs on Fabry's disease medical therapy
Directions to Hospitals Treating Fabry's disease
Risk calculators and risk factors for Fabry's disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Medical Therapy

Specific Treatment

• Enzyme: alpha-galactosidase A enzyme
  • Enzyme replacement therapy: recombinant human enzymes
    • Agalsidase alfa( Replagal)
    • Agalsidase beta (Fabrazyme)
  • Increase the enzyme activity if GLA gene positive: Migalastat